APTANOMICS
Similar Organizations
MicroThermics
MicroThermics is an information technology and biotechnology company.
Polgenix
Polgenix is a small biotech company.
Stopford
Stopford Information Systems is an information technology company.
More informations about "Aptanomics"
Aptanomics Company Profile 2024: Valuation, Investors
Aptanomics has 24 total employees. What industry is Aptanomics in? Aptanomicsโs primary industry is Biotechnology. Is Aptanomics a private or public company? Aptanomics is a Private company. What is Aptanomicsโs current revenue? The current revenue for Aptanomics is โฆSee details»
Aptanomics - Crunchbase Company Profile & Funding
Alternatives and possible competitors to Aptanomics may include MicroThermics, Stopford, and Polgenix. Unlock even more features with Crunchbase Pro Start Your Free TrialSee details»
Aptanomics SA - Drug pipelines, Patents, Clinical trials - Synapse
Explore Aptanomics SA with its drug pipeline, therapeutic area, technology platform, .See details»
Aptanomics: Drug pipelines, Patents, Clinical trials - Synapse
Jun 29, 2023 Explore Aptanomics with its drug pipeline, therapeutic area, technology platform, 1 literature. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for Free. Last โฆSee details»
Aptanomics SA Company Profile, Financial and Strategic SWOT
Aptanomics SA operates as a drug discovery company. It develops small-molecule drugs based on its proprietary peptide aptamer technology. The company is developing Bcl antagonist and โฆSee details»
Aptanomics Information - RocketReach
The Aptanomics annual revenue was $4.2 million in 2023. What is the NAICS code for Aptanomics? The NAICS codes for Aptanomics are [3254, 32, 32541, 325]. What is the SIC โฆSee details»
Aptanomics - Products, Competitors, Financials, Employees, โฆ
Use the CB Insights Platform to explore Aptanomics's full profile. Aptanomics - Products, Competitors, Financials, Employees, Headquarters Locations Technology VendorsSee details»
Aptanomics and Nanosyn collaborate to discover new cancer โฆ
Sep 27, 2005 Aptanomics SA, a specialist in the application of innovative protein technologies for drug discovery, and Nanosyn Inc, a chemistry-based... Close X. Select your language. โฆSee details»
Aptanomics - Crunchbase
The information system in a small biotech company.See details»
Aptanomics Stock Price, Funding, Valuation, Revenue ... - CB Insights
See Aptanomics funding rounds, investors, investments, exits and more. Evaluate their financials based on Aptanomics's post-money valuation and revenue. Aptanomics Stock Price, Funding, โฆSee details»
Aptanomics appoints Michael Courtney as Chairman and Chief
Sep 27, 2005 Lyon, France, June 24, 2003 -- Aptanomics SA, a drug discovery company using proprietary peptide aptamer technology, announced today that...See details»
APTANOMICS Trademark - Registration Number 2739610 - Serial โฆ
Full line of industrial chemical preparations used in producing pharmaceuticals, medicinal preparations, veterinary preparations; chemicals for use in the manufacture of pharmaceutical, โฆSee details»
| BioWorld
Nov 6, 2002 Lyon-based Aptanomics' CEO, John Hawken, a start-up specialist who previously oversaw the creation and early stage development of Neurotech SA, of Evry; Entomed, of โฆSee details»
Collaboration to discover new cancer drugs | Scientist Live
Aptanomics SA, a specialist in the application of protein technologies for drug discovery, and Nanosyn Inc, a chemistry-based company applying its technology for the design, synthesis โฆSee details»
Aptanomics Raises EUR7M For Peptide Aptamer-Based Platform
Aptanomics Raises EUR7M For Peptide Aptamer-Based Platform. Nov. 6, 2002. By James Etheridge. No Comments. BioWorld Asia. Popular Stories. Today's news in brief. BioWorld. โฆSee details»
Research programme: anticancer therapeutics
Aptanomics and Nanosyn have entered into a research collaboration to discover and develop compounds for the treatment of cancer. Aptanomics will apply itsSee details»
Aptanomics and Nanosyn collaborate to discover new cancer โฆ
Sep 27, 2005 Aptanomics SA, a specialist in the application of innovative protein technologies for drug discovery, and Nanosyn Inc, a chemistry-based... Schließen X. Bitte wählen Sie eine โฆSee details»
Research programme: anticancer peptide aptamers - Aptanomics SA
Research programme: anticancer peptide aptamers - Aptanomics SA Alternative Names: AP 1; AP 2; AP 3; Aptamers Latest Information Update: 04 Nov 2017. Price : $50 * Buy Profile. Adis โฆSee details»
Aptanomics, BI Sign Deal In Aptamer Drug Discovery - BioWorld
Aug 3, 2005 Aptanomics, BI Sign Deal In Aptamer Drug Discovery. Aug. 3, 2005. By James Etheridge. No Comments. BioWorld Asia. Popular Stories. Today's news in brief. BioWorld. โฆSee details»
Peptide aptamers as guides for small-molecule drug discovery
1 Aptanomics, 181-203 avenue Jean Jaurès, 69007 Lyon, France. PMID: 16580975 DOI: 10.1016/j.drudis.2006.02.007 Abstract Peptide aptamers are combinatorial protein reagents โฆSee details»